Royalty Pharma plc
RPRX
Pozycja w akcjach
#892
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Cena akcji
$60.39
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$26.89B
Zmiana (1 dzień)
-0.93%
Zmiana (1 rok)
64.87%
Kraj
US
Handel Royalty Pharma plc (RPRX)
Kategoria
Healthcare
Historia stopy dywidendy dla Royalty Pharma plc (RPRX)
Stopa dywidendy (TTM) dla Royalty Pharma plc (symbol akcji: RPRX) na dzień 2023-12-31 wynosi: 2.85%
Średnia stopa dywidendy z ostatnich 5 lat: 2.37%
Średnia stopa dywidendy z ostatnich 5 lat: 2.37%
Historia stopy dywidendy dla Royalty Pharma plc (RPRX) od 2015 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 1.57% | -52.57% |
| 2024 | 3.31% | 16.14% |
| 2023 | 2.85% | 47.67% |
| 2022 | 1.93% | 11.56% |
| 2021 | 1.73% | -15.61% |
| 2020 | 2.05% | -56.29% |
| 2019 | 4.69% | -9.28% |
| 2018 | 5.17% | 10.94% |
| 2017 | 4.66% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
|
| 0.00% |
US
|
